Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization

American Journal Geriatric Pharmacotherapy

Volumn 1, Issue 2, 2003, Pages 75-81

  Balkrishnan, Rajesh ^a   Brent Bond, J ^b   Byerly, Wesley G ^b   Camacho, Fabian T ^b   Anderson, Roger T ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Glaucoma; Health related quality of life; Managed care; Patient outcome; Questionnaire; Topical medication

Indexed keywords

EYE DROPS;

AGED; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIPLE REGRESSION; OPEN ANGLE GLAUCOMA; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; STATISTICAL SIGNIFICANCE; WELLBEING; CROSS-SECTIONAL STUDY; GLAUCOMA; MEDICARE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; STATISTICS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; UNITED STATES;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GLAUCOMA; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MEDICARE; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 15744382692     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1543-5946(03)90003-1     Document Type: Article

References (29)

1. Lee PP, Feldman ZW, Osterman J, et al. Longitudinal prevalence of major eye diseases. Arch Ophthalmol. 2003;121:1303-1310.
2. Sloan FA, Brown DS, Carlisle ES, et al. Estimates of incidence rates with longitudinal data. Arch Ophthalmol. 2003;121:1462-1468.
3. Linden C, Alm A. Prostaglandin analogues in the treatment of glaucoma. Drugs Aging. 1999;14:387-398.
4. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429-440.
5. Lee BL, Wilson MR. Health-related quality of life in patients with cataract and glaucoma. J Glaucoma. 2000;9:87-94.
6. Perfetti S, Varotto A, Massagrandi S, et al. Glaucoma and quality of the life. Acta Ophthalmol Scand Suppl. 1998;76:52.
7. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115:777-784.
8. Sherwood MB, Garcia-Siekavizza A, Meltzer MI, et al. Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology. 1998;105:561-566.
9. Wilson MR, Coleman AL, You F, et al. Functional status and well being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998;105:2112-2116.
10. Parrish RK II, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115:1447-1455.
11. Mills RP. Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. Trans Am Ophthalmol Soc. 1998;96:753-812.
12. Rosenstock IM. Why people use health services. Milbank Mem Fund Q. 1966;44(Suppl):94-127.
13. Anderson RT, Ory M, Cohen S, McBride JS. Issues of aging and adherence to health interventions. Control Clin Trials. 2000;21:17(Suppl 5):171S-183S.
14. Park DC, Jones TR. Medication adherence and aging. In: Fisk AD, Roger WA, eds. Handbook of Human Factors and the Older Adult. San Diego, Calif: Academic Press; 1997:257-288.
15. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: Adherence by the elderly. Am J Public Health. 1993;83:711-716.
16. Montemayor F, Sibley LM, Courtright P, Mikelberg FS. Contribution of multiple glaucoma medications to visual function and quality of life in patients with glaucoma. Can J Ophthalmol. 2001;36:385-390.
17. Halvorsen R, Palmquist R. The interpretation of dummy variables in semilogarithmic equations. Am Econ Rev. 1980;70:474-475.
18. International Classification of Diseases, Ninth Revision, Clinical Modification. Los Angeles, Calif: Practice Management Information Corporation; 1995.
19. Mangione CM, Lee PP, Gutierrez P, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Arch Ophthalmol. 2001;119:1050-1058.
20. Ware JE, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Summary Scales. Boston, Mass: Health Institute, New England Medical Center; 1995.
21. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621.
22. Balkrishnan R, Anderson RT. Predictive power of a risk-assessment questionnaire across different disease states: Results in an elderly managed-care enrolled population. Am J Manag Care. 2001;7:145-153.
23. Greene WH. Econometric Analysis. 3rd ed. Upper Saddle River, NJ: Prentice Hall; 1997.
24. Kennedy P. Estimation with correctly interpreted dummy variables in semilogarithmic equations. Am Econ Rev. 1981;71:801.
25. Cook D, Weisberg S. An Introduction to Regression Graphics. New York: Wiley; 1994.
26. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48:817-838.
27. Rivers PH. Compliance aids - Do they work? Drugs Aging. 1992;2:103-111.
28. Balkrishnan R, Christensen DB. Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments. Asthma. 2000;37:511-517.
29. Balkrishnan R, Christensen DB. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary ailments. Clin Ther. 2000;22:452-469.